Barbora Neprasova

Prague, PR, Czech Republic

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Additive effect of leptin and palm-LEAP2(1-14) ameliorates obesity-induced metabolic stress in ob/ob mice.

Additive effect of leptin and palm-LEAP2(1-14) ameliorates obesity-induced metabolic stress in ob/ob mice.

Journal: European journal of pharmacology

Published: June 16, 2025

Simultaneous treatment with palm-LEAP2(1-14) and feeding high-fat diet attenuates liver lipid metabolism but not obesity: Sign of selective resistance to palm-LEAP2(1-14).

Simultaneous treatment with palm-LEAP2(1-14) and feeding high-fat diet attenuates liver lipid metabolism but not obesity: Sign of selective resistance to palm-LEAP2(1-14).

Journal: Molecular and cellular endocrinology

Published: August 18, 2024

Glutathione Levels and Lipid Oxidative Damage in Selected Organs of Obese Koletsky and Lean Spontaneously Hypertensive Rats.

Glutathione Levels and Lipid Oxidative Damage in Selected Organs of Obese Koletsky and Lean Spontaneously Hypertensive Rats.

Journal: Physiological research

Published: July 19, 2024

Metabolomic Study of Aging in fa/fa Rats: Multiplatform Urine and Serum Analysis.

Metabolomic Study of Aging in fa/fa Rats: Multiplatform Urine and Serum Analysis.

Journal: Metabolites

Published: March 01, 2023

Search for lipidized PrRP analogs with strong anorexigenic effect: In vitro and in vivo studies.

Search for lipidized PrRP analogs with strong anorexigenic effect: In vitro and in vivo studies.

Journal: Neuropeptides

Published: October 08, 2022

Age-related metabolic and neurodegenerative changes in SAMP8 mice.

Age-related metabolic and neurodegenerative changes in SAMP8 mice.

Journal: Aging

Published: February 05, 2022

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.

Lipidized Prolactin-Releasing Peptide as a New Potential Tool to Treat Obesity and Type 2 Diabetes Mellitus: Preclinical Studies in Rodent Models.

Journal: Frontiers in pharmacology

Published: September 27, 2021

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Palmitoylated prolactin-releasing peptide treatment had neuroprotective but not anti-obesity effect in fa/fa rats with leptin signaling disturbances.

Journal: Nutrition & diabetes

Published: July 23, 2021

GPR10 gene deletion in mice increases basal neuronal activity, disturbs insulin sensitivity and alters lipid homeostasis.

GPR10 gene deletion in mice increases basal neuronal activity, disturbs insulin sensitivity and alters lipid homeostasis.

Journal: Gene

Published: October 26, 2020

Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.

Synergistic effect of leptin and lipidized PrRP on metabolic pathways in ob/ob mice.

Journal: Journal of molecular endocrinology

Published: December 06, 2019

Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.

Metabolomic Study of Obesity and Its Treatment with Palmitoylated Prolactin-Releasing Peptide Analog in Spontaneously Hypertensive and Normotensive Rats.

Journal: Journal of proteome research

Published: February 28, 2019

High-fructose drinks affect microRNAs expression differently in lean and obese mice.

High-fructose drinks affect microRNAs expression differently in lean and obese mice.

Journal: The Journal of nutritional biochemistry

Published: May 07, 2018

Showing 1-12 of 14

Last Updated: 09/26/2026